Enjaymo Injection, Solution, Concentrate
Product Images NDC 55292-820

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Enjaymo (NDC 55292-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Recordati Rare Diseases, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1,100 mg/22 mL Vial Carton)

The image shows the carton packaging for Enjaymo (sutimlimab-jome) Injection, 1,100 mg/22 mL (50 mg/mL) concentrate for intravenous infusion. The label displays storage instructions, manufacturer details (Recordati Rare Diseases Inc.), and usage notes. The package is designed for one single-dose vial and includes regulatory information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.